Finally, to confirm that K-Ras also contributes to the maintenance of the tumor-initiating capacity of pancreatic CSCs/CSLCs, we tested the tumor-initiating capacity of K-Ras knockdown cells in the xenograft analysis. The gene discussed is KRAS; the disease is neoplasm.